Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Shahede Khansary, Heidar Tavilani & Hadi Ghasemi. (2023) Gender, Bladder Cancer Healthcare and Burden of COVID-19. Cancer Investigation 41:1, pages 58-69.
Read now
Read now
Kimberly M. Thompson & Kamran Badizadegan. (2022) Health economic analyses of secondary vaccine effects: a systematic review and policy insights. Expert Review of Vaccines 21:3, pages 297-312.
Read now
Read now
Connor Chestnut, Dharmalingam Subramaniam, Prasad Dandawate, Subhash Padhye, John Taylor$suffix/text()$suffix/text(), Scott Weir & Shrikant Anant. (2021) Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review. Nutrition and Cancer 73:11-12, pages 2249-2271.
Read now
Read now
Seona M. Rossi, Timothy Murray, Liam McDonough & Helena Kelly. (2021) Loco-regional drug delivery in oncology: current clinical applications and future translational opportunities. Expert Opinion on Drug Delivery 18:5, pages 607-623.
Read now
Read now
Vipin M. Vashishtha. (2021) Are BCG-induced non-specific effects adequate to provide protection against COVID-19?. Human Vaccines & Immunotherapeutics 17:1, pages 88-91.
Read now
Read now
Mohamed Kacem Ben Fradj, Mokhtar Bibi, Mohamed Bassem Hammami, Amani Kallel, Yassine Nouira & Moncef Feki. (2021) Low Plasma 25-Hydoxyvitamin D at Diagnosis Predicts Poor Outcomes in Patients with Bladder Cancer: A Prospective Cohort Study. Nutrition and Cancer 73:1, pages 55-61.
Read now
Read now
H. S. Darling & Joaquim Bellmunt. (2019) Immunotherapy in non-metastatic urothelial cancer: back to the ‘future’. Expert Opinion on Biological Therapy 19:7, pages 685-695.
Read now
Read now
Diana Groza, Sebastian Gehrig, Pavol Kudela, Martin Holcmann, Christine Pirker, Carina Dinhof, Hemma H. Schueffl, Marek Sramko, Julia Hoebart, Fatih Alioglu, Michael Grusch, Manfred Ogris, Werner Lubitz, Bernhard K. Keppler, Irena Pashkunova-Martic, Christian R. Kowol, Maria Sibilia, Walter Berger & Petra Heffeter. (2018) Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis. OncoImmunology 7:5.
Read now
Read now
Articles from other publishers (37)
Christopher James, Kayeromi Gomez, Shalin Desai, Hiten D. Patel, Goran Rac, Chirag P. Doshi, Ryan Dornbier, Petar Bajic, Thomas Halverson, Gopal N. Gupta, Marcus L. Quek, Alex Gorbonos, Robert Flanigan & Alan J. Wolfe. (2023) Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Jyoti Mohan Tosh, Vikas Kumar Panwar, Ankur Mittal & Arup Kumar Mandal. (2023) Interruption of BCG Therapy for NMIBC During COVID-19 Crisis, Dilemma in Its Continuation: a Review of Available Evidence and Suggested Management Strategies. Indian Journal of Surgical Oncology.
Crossref
Crossref
Nina Marí Gual Pimenta de Queiroz, Fabio Mambelli, Bruno Marques Silva & Sergio Costa Oliveira. (2023) Mutations in genes encoding innate immune molecules identified in bladder cancer samples as potential biomarkers for immunotherapy with BCG and agonists. Frontiers in Urology 3.
Crossref
Crossref
Cade C. LewisAidan J. HeslinCole R FormslagMark R. WakefieldYujiang Fang. (2023) COVID-19 and Prostate Cancer, Can Two Negatives Equal a Positive?. annals of urologic oncology, pages 1-2.
Crossref
Crossref
Theresa Schneider, Lei Zhao, Ziwen Zhu, Gagik Gabrielyan, Huaping Xiao, Emerson D. Fajardo, Qian Bai, Mark R. Wakefield & Yujiang Fang. (2022) The past, present, and future of immunotherapy for bladder tumors. Medical Oncology 39:12.
Crossref
Crossref
Alberto D’Angelo, Robert Chapman, Marianna Sirico, Navid Sobhani, Martina Catalano, Enrico Mini & Giandomenico Roviello. (2022) An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next. Cancer Chemotherapy and Pharmacology 90:3, pages 191-205.
Crossref
Crossref
Benjamin Y. Klein, Charles L. Greenblatt, Ofer N. Gofrit & Hervé Bercovier. (2022) Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Gönül Aslan & Deniz Alkaya. (2022) One Hundred of Tuberculosis Vaccine: History of Bacille Calmette-Guérin - Could BCG Vaccination Induce Trained Immunity?. Turkish Journal of Immunology 10:1, pages 12-21.
Crossref
Crossref
Ekaterina V. Kulchavenya, Denis P. Kholtobin & Elena V. Telina. (2022) Impact of the COVID-19 pandemic on the work of urological departments. Urology reports (St. - Petersburg) 12:1, pages 5-12.
Crossref
Crossref
Suha Abu Khalaf, Dima Dandachi, Bruno P Granwehr & Maria C Rodriguez-Barradas. (2023) Cancer Immunotherapy in Adult Patients with HIV. Journal of Investigative Medicine 70:4, pages 883-891.
Crossref
Crossref
Kent J. Koster, Hilary L. Webb & Jeffrey D. Cirillo. (2021) COVID-19 and Beyond: Exploring Public Health Benefits from Non-Specific Effects of BCG Vaccination. Microorganisms 9:10, pages 2120.
Crossref
Crossref
Nina M. G. P. de Queiroz, Fabio V. Marinho, Ana Carolina V. S. C. de Araujo, Julia S. Fahel & Sergio C. Oliveira. (2021) MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model. Scientific Reports 11:1.
Crossref
Crossref
Stefano Burgio, Everly Conway de Macario, Alberto JL Macario & Francesco Cappello. (2021) SARS-CoV-2 in patients with cancer: possible role of mimicry of human molecules by viral proteins and the resulting anti-cancer immunity. Cell Stress and Chaperones 26:4, pages 611-616.
Crossref
Crossref
Maya Kulshekar, Shridhar C. Ghagane, Sridevi I. Puranik, Rajendra B. Nerli & Murigendra B. Hiremath. 2021. Monoclonal Antibodies. Monoclonal Antibodies.
Zhenyu Nie, Mei Chen, Xiaohong Wen, Yuanhui Gao, Denggao Huang, Hui Cao, Yanling Peng, Na Guo, Jie Ni & Shufang Zhang. (2021) Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Danielle Klinger, Brian L. Hill, Noam Barda, Eran Halperin, Ofer N. Gofrit, Charles L. Greenblatt, Nadav Rappoport, Michal Linial & Hervé Bercovier. (2021) Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease. Vaccines 9:5, pages 491.
Crossref
Crossref
Ding Wang, Xiaodong Wei, Dhan V. Kalvakolanu, Baofeng Guo & Ling Zhang. (2021) Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy. Frontiers in Immunology 12.
Crossref
Crossref
Stamatia Pouliliou, Christos Nikolaidis & George Drosatos. (2020) Current trends in cancer immunotherapy: a literature-mining analysis. Cancer Immunology, Immunotherapy 69:12, pages 2425-2439.
Crossref
Crossref
Mohamed F. Allam & Ghada E.EL-D. Amin. (2020) BCG Vaccine does not Protect Against COVID-19. The Open Respiratory Medicine Journal 14:1, pages 45-46.
Crossref
Crossref
B. V. Karalnik, B. I. Alimbekova & L. T. Eralieva. (2020) Coronavirus Infection and BCG Vaccination: Facts and Possibilities. Epidemiology and Vaccinal Prevention 19:5, pages 18-24.
Crossref
Crossref
Xinlan Yang. (2020) Immunotherapies For Cancer, a Promising Cure?. Immunotherapies For Cancer, a Promising Cure?.
Zhilin Chen & Boris Julg. (2020) Therapeutic Vaccines for the Treatment of HIV. Translational Research 223, pages 61-75.
Crossref
Crossref
M. Nadir BhuiyanRavindra GaneshAmit K. Ghosh. (2020) COVID-19: A 2020 update. Indian Journal of Medical Sciences 72, pages 88-94.
Crossref
Crossref
Elisa Nemes, Shabaana A. Khader, Rosemary V. Swanson & Willem A. Hanekom. (2020) Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB. Frontiers in Immunology 11.
Crossref
Crossref
E. I. Olekhnovich, A. I. Manolov, A. V. Pavlenko, D. N. Konanov, D. E. Fedorov, P. O. Tikhonova, O. E. Glushchenko & E. N. Ilina. (2020) The Effect of Intestinal Microbiome on the Effectiveness of Antitumor Immunotherapy. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 14:3, pages 241-251.
Crossref
Crossref
Inas K. Sharquie. (2020) BCG is a Good Immunotherapeutic Agent for Viral and Autoimmune Diseases: Is it a New Weapon against Coronavirus (COVID-19)?. Electronic Journal of General Medicine 17:6, pages em229.
Crossref
Crossref
E.I. Olekhnovich, A.I. Manolov, A.V. Pavlenko, D.N. Konanov, D.E. Fedorov, P.O. Tikhonova, O.E. Glushchenko & E.N. Ilina. (2020) Intestinal microbiom modulates the response to antitumor immunotherapy. Biomeditsinskaya Khimiya 66:1, pages 54-63.
Crossref
Crossref
Zuzanna Urban-Wojciuk, Mohd M. Khan, Benjamin L. Oyler, Robin Fåhraeus, Natalia Marek-Trzonkowska, Aleksandra Nita-Lazar, Ted R. Hupp & David R. Goodlett. (2019) The Role of TLRs in Anti-cancer Immunity and Tumor Rejection. Frontiers in Immunology 10.
Crossref
Crossref
J. Spencer Keith, Mahmoud I. Khalil, Mohamed H. Kamel, Rodney Davis & Ehab Eltahawy. (2019) Effects and Complications of Intravesical Instillation of Bacillus Calmette-Guerin Therapy. Current Bladder Dysfunction Reports 14:2, pages 58-66.
Crossref
Crossref
Weijie Zhou, Yue Yin, Emery Smith, Jacqueline Chou, Justin Shumate, Louis Scampavia, Timothy P. Spicer, Nicholas Carpino & Jarrod B. French. (2018) Discovery and Characterization of Two Classes of Selective Inhibitors of the Suppressor of the TCR Signaling Family of Proteins. ACS Infectious Diseases 5:2, pages 250-259.
Crossref
Crossref
D. S. Mikhaylenko, S. A. Sergienko, I. N. Zaborsky, K. N. Saflullin, S. A. Serebryany, N. Yu. Safronova, M. V. Nemtsova, A. D. Kaprin & B. Ya. Alekseev. (2019) The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer. Cancer Urology 14:4, pages 124-138.
Crossref
Crossref
Sudeep Kumar. 2019. Pharmaceuticals from Microbes. Pharmaceuticals from Microbes
39
73
.
Estela Noguera-Ortega & Esther Julián. 2018. Mycobacterium - Research and Development. Mycobacterium - Research and Development.
Rogério C. da Silva, Joel G. de Souza, Amedea B. Seabra, Nelson Durán & Wagner J. Fávaro. (2018) Advances and Perspectives in Urinary Bladder Cancer Nanotherapy. EMJ Urology, pages 52-61.
Crossref
Crossref
Natalie E. Nieuwenhuizen, Prasad S. Kulkarni, Umesh Shaligram, Mark F. Cotton, Cyrill A. Rentsch, Bernd Eisele, Leander Grode & Stefan H. E. Kaufmann. (2017) The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing. Frontiers in Immunology 8.
Crossref
Crossref
Danay Saavedra & Tania Crombet. (2017) CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients. Frontiers in Immunology 8.
Crossref
Crossref
Farouk Tijjani Saad, Evren Hincal & Bilgen Kaymakamzade. (2017) Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer. Computational and Mathematical Methods in Medicine 2017, pages 1-9.
Crossref
Crossref